[Coronary angioplasty in the acute phase of myocardial infarct]

Area of Science:

• Cardiology
• Interventional Cardiology
• Acute Myocardial Infarction Treatment

Context:

• Primary percutaneous coronary intervention (PCI) is a key reperfusion strategy for ST-elevation myocardial infarction.
• Thrombolysis has been the traditional treatment, but PCI offers an alternative with potential advantages.
• Growing evidence supports PCI's role in managing acute coronary syndromes.

Purpose:

• To review and synthesize evidence comparing primary percutaneous coronary intervention (PCI) with thrombolysis for acute myocardial infarction (AMI).
• To evaluate the impact of primary PCI on mortality, morbidity, and specific adverse events.
• To identify patient subgroups who may benefit most from primary PCI.

Summary:

• Primary PCI demonstrates a reduction in mortality and morbidity, including recurrent ischemia and hemorrhagic stroke, when compared to thrombolysis.
• Studies indicate that the benefits of primary PCI are more substantial in high-risk patient populations.
• These high-risk groups include patients with cardiogenic shock, anterior wall infarction, the elderly, and those with contraindications to or non-diagnostic electrocardiograms for thrombolysis.

Impact:

• Primary PCI represents an effective reperfusion strategy for acute myocardial infarction, offering improved patient outcomes.
• The findings support the expanded use of primary PCI, particularly in vulnerable patient cohorts.
• This evidence guides clinical decision-making towards optimizing treatment selection for acute myocardial infarction to reduce long-term complications.